A phase 1b trial to study the safety and effect of ZP9830 in patients with plaque psoriasis

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2026-525220-15-00

Enrollment

Registered

2026-07-01

Start date

Unknown

Completion date

Unknown

Last updated

2026-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plaque Psoriasis

None listed

Sex/Gender

All

Age

18 Years to 64 Years

None listed

Source: EU CTIS · Data processed: Jul 2, 2026